William Oh, MD, Deputy Director, The Tisch Cancer Institute, Mt. Sinai Health System, Discusses How PSA Is Valuable As A Biomarker In The Treatment Of Prostate Cancer. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.
http://obroncology.com
Advertisement